Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.

Issue 36, 2014
Previous Article Next Article

Structural characterization of form I of anhydrous rifampicin

Author affiliations


Rifampicin is a first-line drug widely used in the treatment of tuberculosis both in the intensive and in the treatment phase. In this work we characterized the crystal structure of form I of anhydrous rifampicin mainly by using X-ray powder diffraction data combined with the Rietveld method. Other complementary techniques such as Fourier transform infrared spectroscopy and thermal analysis were also employed. It crystallized in a monoclinic crystal system with space group C2 and the following unit cell parameters: a = 25.8846(2) Å, b = 14.2965(2) Å, c = 14.2796(2) Å, β = 122.98(1)°, V = 4432.81(7) Å3, Z = 4, Z′ = 1 and ρcalc = 1.23310(2) g cm−3. A BFDH model was used to inspect the crystal morphology prediction, and great similarity with crystals observed on an optical microscope was found. The FTIR spectrum confirmed the results obtained by X-ray powder diffraction, which indicates that all the functional groups involved in H bonding are intramolecularly connected. This polymorphic form presented a thermal stability up to approximately 230 °C.

Graphical abstract: Structural characterization of form I of anhydrous rifampicin

Back to tab navigation

Supplementary files

Article information

06 Jun 2014
07 Jul 2014
First published
07 Jul 2014

CrystEngComm, 2014,16, 8555-8562
Article type
Author version available

Structural characterization of form I of anhydrous rifampicin

A. L. Ibiapino, R. C. Seiceira, A. Pitaluga, A. C. Trindade and F. F. Ferreira, CrystEngComm, 2014, 16, 8555
DOI: 10.1039/C4CE01157K

Social activity

Search articles by author